Investigation of mitochondrial calcium uniporter role in embryonic and adult motor neurons from G93AhSOD1 mice

Vedrana Tadić*, Adam Adam, Nadine Goldhammer, Janin Lautenschlaeger, Moritz Oberstadt, Ayse Malci, Thanh Tu Le, Saikata Sengupta, Beatrice Stubendorff, Silke Keiner, Otto W. Witte, Julian Grosskreutz

*Corresponding author for this work
14 Citations (Scopus)

Abstract

Amyotrophic lateral sclerosis is characterized by progressive death of motor neurons (MNs) with glutamate excitotoxicity and mitochondrial Ca2+ overload as critical mechanisms in disease pathophysiology. We used MNs from G93AhSOD1 and nontransgenic embryonic cultures and adult mice to analyze the expression of the main mitochondrial calcium uniporter (MCU). MCU was overexpressed in cultured embryonic G93AhSOD1 MNs compared to nontransgenic MNs but downregulated in MNs from adult G93AhSOD1 mice. Furthermore, cultured embryonic G93AhSOD1 were rescued from kainate-induced excitotoxicity by the Ca2+/calmodulin-dependent protein kinase type II inhibitor; KN-62, which reduced MCU expression in G93AhSOD1 MNs. MCU activation via kaempferol neither altered MCU expression nor influenced MN survival. However, its acute application served as a fine tool to study spontaneous Ca2+ activity in cultured neurons which was significantly altered by the mutated hSOD1. Pharmacological manipulation of MCU expression might open new possibilities to fight excitotoxic damage in amyotrophic lateral sclerosis.

Original languageEnglish
JournalNeurobiology of Aging
Volume75
Pages (from-to)209-222
Number of pages14
ISSN0197-4580
DOIs
Publication statusPublished - 03.2019
Externally publishedYes

Funding

This research is supported by BMBF, Germany (Bundesministerium für Bildung and Forschung) in the framework of the E-RARE program (PYRAMID, 01GM1304 ) and JPND (SOPHIA, 01ED1202B ) of the European Union to JG and the Deutsche Gesellschaft für Muskelkranke e.V. (DGM) in collaboration with the German Network for Motoneuron Disease (MND-NET). Furthermore, it is supported by an ALS Young Investigator Research Scholarship by the Deutsche Gesellschaft für Muskelkranke (DGM) and a Junior Research Grant by the Medical Faculty, University of Leipzig, to MO. JL was supported by a research fellowship from the Deutsche Forschungsgemeinschaft (DFG; award LA 3609/2-1). For the technical assistance, the authors thank Svetlana Tausch and Madlen Günther.

Research Areas and Centers

  • Centers: Center for Neuromuscular Diseases

Cite this